[1]
“Chemical Modulation of Amyloid Beta Oligomer’s in Alzheimer’s Disease”, Am. J. Chem. Pharm., vol. 4, no. 1, pp. 16–28, Jun. 2025, doi: 10.54536/ajcp.v4i1.4886.